Pretransplant left ventricular hypertrophy in association with postoperative myocardial injury in liver transplantation. Issue 5 (16th March 2020)

• Record Type: Journal Article
• Authors: Sun, Kai; Wang, Yun; Yan, Min; Xia, Victor W.
• Is Part Of: Clinical transplantation. Volume 34:Issue 5(2020)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2020-03-16
• Subjects: hypertrophy -- left ventricular -- liver transplantation -- myocardial injury; Transplantation of organs, tissues, etc -- Periodicals; 617.95
• DOI: 10.1111/ctr.13847
• Languages: English
• ISSNs: 0902-0063

Abstract

Abstract: Pretransplant left ventricular hypertrophy (LVH) is a common finding during preoperative cardiac evaluation. We hypothesized that patients with pretransplant LVH were associated with a higher risk of postoperative myocardial injury (PMI) in adult patients undergoing liver transplantation (LT). A retrospective cohort analysis was performed by reviewing the medical records of adult patients who underwent LT between January 2006 and October 2013. Of 893 patients, the incidences of mild, moderate, and severe LVH were 7.8%, 5.6%, and 2.5%, respectively. Propensity match was used to eliminate the pretransplant imbalance between the LVH and non‐LVH groups. In after‐match patients, 23.5% of LVH patients developed PMI compared to 11.8% in the control group ( P = .011). The incidence of PMI in patients with moderate‐severe degrees of LVH was significantly higher compared with that in patients with mild LVH (27.9% vs 19.1%, P = .016). When controlling intraoperative variables, patients with LVH had 4.5 higher odds of developing PMI (95% CI1.18‐17.19, P = .028). Patients experiencing PMI had significantly higher 1‐year mortality (37.5% vs 15.7%, log‐rank test P < .001). Our results suggest that patients with pretransplant LVH were at a high risk of developing PMI and should be monitored closely in the perioperative period. More studies are warranted.